XOMA Royalty Corporation – Filings and Transcripts

NASDAQ: XOMA
Share price (6/2/26): $41.69
Market cap (6/2/26): $523 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Business combination disclosure

Registration of securities for employees

Third party tender offer – amended

Third party tender offer – amended

Third party tender offer – amended

Ownership Filter

Wyszomierski Jack L

Limber Joseph M

Hernday Natasha

Perry Matthew D

Franklin Heather L

News Filter

Change in Directors, Officers or Compensation, Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Shareholder Vote Results, Financial Statements or Exhibits

Material Definitive Agreement, Financial Statements or Exhibits

Completion of Acquisition or Disposition of Assets, Other Events, Financial Statements or Exhibits

Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator

Reports 2025 Financial Results and Highlights Recent Business Achievements

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Correspondence with the SEC

Scanned paper annual report submission

Notice of effectiveness

Notice of effectiveness